Investment & Finance
Cannabis Stocks in 2026: What Is Listed, What Is Next and How the Market Trades
Why are cannabis listings so relevant in 2026?
cannabis investment
60stories
13 Octlast updated
More in cannabis investment
- Investment & Finance
Cannabis at an Inflexion Point: A Structural Repricing Ahead
Having spent over 30 years in advisory roles in financial markets prior to entering the cannabinoid industry, I lived through many hyperbolic boom/bust market cycles.
- Investment & Finance
Cannabis at an Inflexion Point: Why Capital Is Missing the Opportunity
For much of the past five years, the cannabis industry has been defined by disappointment.
- M&A Activity
Cannabis Telehealth Platform Veri Medtech Sets Terms for $15m Nasdaq IPO
Veriheal parent Veri Medtech Holdings has priced a $15m IPO at $4 per share, with plans to uplist from the OTC market to Nasdaq.
- M&A Activity
Cannara Biotech Acquires Medican Organic in $2.8m Deal, Cementing Quebec Cultivation Footprint
Cannara Biotech has completed its $2.8m all-cash acquisition of Medican Organic, finalising ownership of the Valleyfield cultivation operation it first acquired in 2021.
- M&A Activity
ACE Venture Completes 51% Acquisition of Vireo Health New York, Launching Boukét Cannabis Lifestyle Brand
ACE Venture has closed its 51% acquisition of Vireo Health New York, taking control of the vertically integrated medical operator and unveiling Boukét as a new cannabis lifestyle brand for the state.
- M&A Activity
Nabis Acquires Hudson Distribution Licence to Enter New Jersey Cannabis Market
Cannabis wholesale platform Nabis is acquiring Hudson Distribution Services’ New Jersey distribution licence and warehouse lease, marking its entry into a fourth US state.
- M&A Activity
Vireo Growth Acquires FLUENT in All-Stock Deal, Expanding Florida Cannabis Footprint
Cannabis multi-state operator Vireo Growth has agreed to acquire Florida-based FLUENT in an all-stock deal, creating a combined operator with around 74 stores in the state and accelerating consolidation across US MSOs.
- M&A Activity
Has Rescheduling Accelerated the Cannabis M&A Wave?
Last week’s rescheduling announcement has placed a spotlight firmly on the medical cannabis arms of North America’s largest operators.
